Cargando…
Therapeutic status of hydroxychloroquine in COVID-19: A review
Hydroxychloroquine (HCQ), a 4-aminoquinoline, is used worldwide mainly for its role in management of malaria and rheumatoid arthritis. In the present pandemic of coronavirus disease (COVID)-2019, the drug is being repurposed, based on its in vitro evidence of efficacy against coronavirus. There has...
Autores principales: | Kaur, Kirandeep, Kaushal, Sandeep, Kaushal, Ishita Gupta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573985/ https://www.ncbi.nlm.nih.gov/pubmed/33100674 http://dx.doi.org/10.4103/joacp.JOACP_313_20 |
Ejemplares similares
-
COVID-19 and the Radiology Department: What We Know So Far
por: Vermani, Sanya, et al.
Publicado: (2020) -
Epidemiological and Clinical Characteristics of 6635 COVID-19 Patients: a Pooled Analysis
por: Kaur, Nirmaljot, et al.
Publicado: (2020) -
COVID-19 and its Modes of Transmission
por: Karia, Rutu, et al.
Publicado: (2020) -
Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications
por: Kumar, Rajnish, et al.
Publicado: (2021) -
Ventricular Arrhythmia Risk Based on Ethnicity in COVID-19 Patients on Hydroxychloroquine and Azithromycin Combination: Viewpoint
por: Roy, Sayak, et al.
Publicado: (2020)